Search results for Parsatuzumab
Parsatuzumab, Abbexa, abx831258
Parsatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EGFL7, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Parsatuzumab is under investigation in clinical trial NCT01366131, Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Parsatuzumab Biosimilar - Research Grade, ichor.bio, ICH5175
Detects human EGFL7
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Parsatuzumab (HV171016), abinScience, HV171016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.